AMSilk, a global leader in advanced biomaterials made from silk proteins, today announces that its bioengineered yarns have been featured in Balenciaga’s 55^th Couture Collection.

An evening cocoon gown, constructed using an AMSilk-blend fabric, appeared as part of Creative Director Pierpaolo Piccioli's debut Couture Collection for Balenciaga. The design celebrates the versatility and inherent lightness of AMSilk’s bioengineered yarns and represents the latest exciting development in the Company’s pioneering collaboration with the House.

The collaboration is emblematic of the luxury fashion industry’s increasing focus on scalable, sustainable alternatives to conventional fabrics, including silk, and the simultaneous evolution of AMSilk’s bioengineered yarns, which don’t compromise on quality or aesthetics.

Ulrich Scherbel, Chief Operating Officer Premium Filaments at AMSilk said: "Seeing our material feature so prominently as part of the Balenciaga Couture Collection is a meaningful milestone for AMSilk. Haute Couture has always been defined by exceptional craftsmanship and extraordinary materials. For us, this latest application represents an important validation of our technology and demonstrates the growing potential of biotechnology-enabled materials in luxury fashion. We are proud to be advancing this journey together with visionary partners such as Balenciaga."

AMSilk’s advanced biomaterials are inspired by spider silk. By decoding and reengineering nature's protein blueprint, AMSilk produces silk proteins via precision fermentation and converts them into wet-spun filaments. The result is a unique filament engineered for luxury-grade aesthetics and consistency while remaining fully compatible with established textile manufacturing processes such as knitting, weaving, dyeing and finishing. Completely protein-based, fully biodegradable, and microplastic-free, AMSilk’s advanced biomaterials herald a new era in material innovation.